Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants final approval for Teva's generic nasal spray formulation of opioid overdose reversal drug naloxone hydrochloride

firstwordpharmaApril 21, 2019

Tag: FDA , teva , generic nasal spray

PharmaSources Customer Service